Stay updated on Psilocybin Bioavailability in Adult Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Bioavailability in Adult Clinical Trial page.

Latest updates to the Psilocybin Bioavailability in Adult Clinical Trial page
- Check6 days agoChange DetectedThe error page’s footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe Study Record page now shows a 403 Forbidden error, replacing the usual study details with an access-denied message. The surrounding layout remains, but users cannot access the study content from this page.SummaryDifference17%

- Check48 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a metadata update to the ClinicalTrials.gov record. This reflects a minor version change rather than substantive content changes.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page footer’s revision indicator was updated from v3.6.4 to v3.6.5, signaling a new build of the page without changes to content or functionality.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now displays Revision: v3.6.4 in the footer, replacing v3.6.3, indicating a minor site revision. This update does not alter the study details or data presented on the record.SummaryDifference0.1%

- Check105 days agoChange DetectedA new revision tag Revision: v3.6.3 appears on the page, replacing the previous Revision: v3.6.2. This indicates a minor site update and does not alter the study details.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Bioavailability in Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Bioavailability in Adult Clinical Trial page.